Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

UroGen Pharma (URGN) Asset Utilization Ratio (2019 - 2025)

Historic Asset Utilization Ratio for UroGen Pharma (URGN) over the last 9 years, with Q3 2025 value amounting to 0.49.

  • UroGen Pharma's Asset Utilization Ratio rose 6012.71% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 6012.71%. This contributed to the annual value of 0.39 for FY2024, which is 2606.0% down from last year.
  • According to the latest figures from Q3 2025, UroGen Pharma's Asset Utilization Ratio is 0.49, which was up 6012.71% from 0.41 recorded in Q2 2025.
  • UroGen Pharma's 5-year Asset Utilization Ratio high stood at 0.7 for Q2 2023, and its period low was 0.18 during Q1 2021.
  • Its 5-year average for Asset Utilization Ratio is 0.4, with a median of 0.38 in 2022.
  • In the last 5 years, UroGen Pharma's Asset Utilization Ratio surged by 18022240.26% in 2021 and then tumbled by 4938.14% in 2024.
  • Quarter analysis of 5 years shows UroGen Pharma's Asset Utilization Ratio stood at 0.38 in 2021, then grew by 29.02% to 0.49 in 2022, then fell by 8.75% to 0.44 in 2023, then crashed by 30.83% to 0.31 in 2024, then skyrocketed by 59.34% to 0.49 in 2025.
  • Its last three reported values are 0.49 in Q3 2025, 0.41 for Q2 2025, and 0.34 during Q1 2025.